Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL798P, or RNA, 7SL, cytoplasmic 798, pseudogene, is classified as a pseudogene, meaning it is a segment of DNA that closely resembles a functional gene but does not encode a functional product[1][4]. It derives from the gene encoding 7SL RNA, a crucial non-coding RNA which is a core part of the signal recognition particle (SRP) complex responsible for directing proteins to the endoplasmic reticulum during translation[1][5]. However, as a pseudogene, RN7SL798P is nonfunctional; it does not contribute to SRP activity or protein targeting[1][4]. While the parental 7SL RNA has architectural and regulatory roles essential for protein sorting and stress responses, RN7SL798P does not participate in these processes[1][3][5]. Pseudogenes like RN7SL798P are generally non-functional, though they may occasionally be transcribed at low levels without biological significance[4]. RN7SL798P is not considered a therapeutic target and does not have known roles in disease, drug interactions, or use as a biomarker[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 798, pseudogene (RN7SL798P).